BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 8583883)

  • 1. [Mental disorders of drug addicts in treatment: a study of prevalence with retrospective evaluation by means of structured diagnostic interviews].
    Pozzi G; Tacchini G; Di Giannantonio M; Tempesta E
    Minerva Psichiatr; 1995 Sep; 36(3):139-54. PubMed ID: 8583883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
    Grolleau A; Cougnard A; Bégaud B; Verdoux H
    Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
    Simmons LA; Havens JR
    J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-morbid post-traumatic stress disorder in a substance misusing clinical population.
    Reynolds M; Mezey G; Chapman M; Wheeler M; Drummond C; Baldacchino A
    Drug Alcohol Depend; 2005 Mar; 77(3):251-8. PubMed ID: 15734225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
    Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidity in young heroin users.
    Rodríguez-Llera MC; Domingo-Salvany A; Brugal MT; Silva TC; Sánchez-Niubó A; Torrens M;
    Drug Alcohol Depend; 2006 Sep; 84(1):48-55. PubMed ID: 16388919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program.
    Kidorf M; Disney ER; King VL; Neufeld K; Beilenson PL; Brooner RK
    Drug Alcohol Depend; 2004 May; 74(2):115-22. PubMed ID: 15099655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic co-morbidity in 2300 psychiatric out-patients presenting for treatment evaluated with a semi-structured diagnostic interview.
    Zimmerman M; McGlinchey JB; Chelminski I; Young D
    Psychol Med; 2008 Feb; 38(2):199-210. PubMed ID: 17949515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being.
    Degenhardt L; Hall W
    Nicotine Tob Res; 2001 Aug; 3(3):225-34. PubMed ID: 11506766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study.
    Feinstein A; Stergiopoulos V; Fine J; Lang AE
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(3):169-76. PubMed ID: 11513100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of psychiatric and substance use disorders among single mothers nearing lifetime welfare eligibility limits.
    Cook JA; Mock LO; Jonikas JA; Burke-Miller JK; Carter TM; Taylor A; Petersen CA; Grey DD; Gruenenfelder D
    Arch Gen Psychiatry; 2009 Mar; 66(3):249-58. PubMed ID: 19255374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual diagnosis in Spain.
    Gual A
    Drug Alcohol Rev; 2007 Jan; 26(1):65-71. PubMed ID: 17364838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of DSM-IV disorders and attendant help-seeking in 2 American Indian reservation populations.
    Beals J; Manson SM; Whitesell NR; Spicer P; Novins DK; Mitchell CM
    Arch Gen Psychiatry; 2005 Jan; 62(1):99-108. PubMed ID: 15630077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
    Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.